Sign in

Research summary ·

A meta-analysis of berberine combined with brain-gut axis-targeted agents for diarrhoea-predominant irritable bowel syndrome.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This review looked at IBS-D, a type of IBS with mainly diarrhoea. The team asked if berberine helps when added to brain-gut drugs. Berberine is a substance found in nature. On 1 December 2025, they searched many databases for trials. In these trials, people were put into groups by chance. They pooled 19 trials with 1,489 people in total.

What they found

People on the combined drugs did better than the control groups. Their IBS-D symptoms eased, and their quality of life rose. More people had a good overall response to treatment. Belly pain and bloating got less severe. Diarrhoea symptoms also got better. No trial reported serious harms.

What it means for patients

The authors say the combined drugs may help people with IBS-D. They see early signs of benefit, but not proof. They also say the safety looked acceptable. But they stress the proof is not yet strong enough.

Why it is not certain yet

The trials in this review were small. The trials also had weak points in how they were done. Overall, the strength of the proof is still too low. Larger and well-designed trials are still needed to check the results. A review can only be as good as the studies in it. The abstract does not say how long people were followed.

Source

A meta-analysis of berberine combined with brain-gut axis-targeted agents for diarrhoea-predominant irritable bowel syndrome.

PubMed · PMID 42877511

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Irritable bowel syndrome publications